{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:10:22Z","timestamp":1790939422690,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7199","license":[{"start":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T00:00:00Z","timestamp":1210723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T00:00:00Z","timestamp":1210723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2008,6,26]]},"DOI":"10.1038\/nature06956","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T17:35:34Z","timestamp":1210786534000},"page":"1258-1261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":480,"title":["Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants"],"prefix":"10.1038","volume":"453","author":[{"given":"Patrick J.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley F.","family":"Haire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Pu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Skehel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,14]]},"reference":[{"key":"BFnature06956_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/ja963036t","volume":"119","author":"CU Kim","year":"1997","unstructured":"Kim, C. U. et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119, 681\u2013690 (1997)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature06956_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein, M. et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418\u2013423 (1993)","journal-title":"Nature"},{"key":"BFnature06956_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","volume":"6","author":"JN Varghese","year":"1998","unstructured":"Varghese, J. N. et al. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6, 735\u2013746 (1998)","journal-title":"Structure"},{"key":"BFnature06956_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","volume":"47","author":"JL McKimm-Breschkin","year":"2000","unstructured":"McKimm-Breschkin, J. L. Resistance of influenza viruses to neuraminidase inhibitors\u2013a review. Antiviral Res. 47, 1\u201317 (2000)","journal-title":"Antiviral Res."},{"key":"BFnature06956_CR5","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1128\/AAC.45.12.3403-3408.2001","volume":"45","author":"LV Gubareva","year":"2001","unstructured":"Gubareva, L. V., Webster, R. G. & Hayden, F. G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob. Agents Chemother. 45, 3403\u20133408 (2001)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature06956_CR6","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong, M. D. et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353, 2667\u20132672 (2005)","journal-title":"N. Engl. J. Med."},{"key":"BFnature06956_CR7","doi-asserted-by":"publisher","first-page":"12418","DOI":"10.1128\/JVI.01067-07","volume":"81","author":"HL Yen","year":"2007","unstructured":"Yen, H. L. et al. Neuraminidase inhibitor-resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo . J. Virol. 81, 12418\u201312426 (2007)","journal-title":"J. Virol."},{"issue":"5","key":"BFnature06956_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2807\/ese.13.05.08026-en","volume":"13","author":"A Lackenby","year":"2008","unstructured":"Lackenby, A. et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 13, (2008)","journal-title":"Eurosurveillance"},{"key":"BFnature06956_CR9","first-page":"1397","volume-title":"Fields Virology","author":"BR Murphy","year":"1996","unstructured":"Murphy, B. R. & Webster, R. G. in Fields Virology 3rd edn (eds Fields, D. B. N., Knipe, M. & Howley, P. M.) 1397\u20131445 (Lippincott-Raven, Philadelphia, 1996)"},{"key":"BFnature06956_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/303035a0","volume":"303","author":"JN Varghese","year":"1983","unstructured":"Varghese, J. N., Laver, W. G. & Colman, P. M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9\u2009\u00c5 resolution. Nature 303, 35\u201340 (1983)","journal-title":"Nature"},{"key":"BFnature06956_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/prot.340020205","volume":"2","author":"AT Baker","year":"1987","unstructured":"Baker, A. T., Varghese, J. N., Laver, W. G., Air, G. M. & Colman, P. M. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2, 111\u2013117 (1987)","journal-title":"Proteins"},{"key":"BFnature06956_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0969-2126(93)90005-2","volume":"1","author":"WP Burmeister","year":"1993","unstructured":"Burmeister, W. P., Henrissat, B., Bosso, C., Cusack, S. & Ruigrok, R. W. Influenza B virus neuraminidase can synthesize its own inhibitor. Structure 1, 19\u201326 (1993)","journal-title":"Structure"},{"key":"BFnature06956_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1386-6532(00)00111-6","volume":"18","author":"J Ives","year":"2000","unstructured":"Ives, J. et al. Anti-viral drug resistance: An oseltamivir treatment-selected influenza A\/N2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo . J. Clin. Virol. 18, 251\u2013269 (2000)","journal-title":"J. Clin. Virol."},{"key":"BFnature06956_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","volume":"55","author":"JAL Ives","year":"2002","unstructured":"Ives, J. A. L. et al. The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo . Antiviral Res. 55, 307\u2013317 (2002)","journal-title":"Antiviral Res."},{"key":"BFnature06956_CR15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1086\/424572","volume":"190","author":"ML Herlocher","year":"2004","unstructured":"Herlocher, M. L. et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J. Infect. Dis. 190, 1627\u20131630 (2004)","journal-title":"J. Infect. Dis."},{"key":"BFnature06956_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1086\/318537","volume":"183","author":"LV Gubareva","year":"2001","unstructured":"Gubareva, L. V., Kaiser, L., Matrosovich, M. N., Soo-Hoo, Y. & Hayden, F. G. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183, 523\u2013531 (2001)","journal-title":"J. Infect. Dis."},{"key":"BFnature06956_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso, M. et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364, 759\u2013765 (2004)","journal-title":"Lancet"},{"key":"BFnature06956_CR18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/4371108a","volume":"437","author":"QM Le","year":"2005","unstructured":"Le, Q. M. et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437, 1108 (2005)","journal-title":"Nature"},{"key":"BFnature06956_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3201\/eid1309.070164","volume":"13","author":"JL McKimm-Breschkin","year":"2007","unstructured":"McKimm-Breschkin, J. L., Selleck, P. W., Usman, T. B. & Johnson, M. A. Reduced sensitivity of influenza A to oseltamivir. Emerg. Infect. Dis. 13, 1354\u20131357 (2007)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature06956_CR20","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1128\/AAC.00645-06","volume":"50","author":"MA Rameix-Welti","year":"2006","unstructured":"Rameix-Welti, M. A. et al. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob. Agents Chemother. 50, 3809\u20133815 (2006)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature06956_CR21","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","volume":"46","author":"MZ Wang","year":"2002","unstructured":"Wang, M. Z., Tai, C. Y. & Mendel, D. B. Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob. Agents Chemother. 46, 3809\u20133816 (2002)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature06956_CR22","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","volume":"49","author":"HL Yen","year":"2005","unstructured":"Yen, H. L. et al. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 49, 4075\u20134084 (2005)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature06956_CR23","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1021\/jm010528u","volume":"45","author":"BJ Smith","year":"2002","unstructured":"Smith, B. J. et al. Structural studies of the resistance of influenza virus neuramindase to inhibitors. J. Med. Chem. 45, 2207\u20132212 (2002)","journal-title":"J. Med. Chem."},{"key":"BFnature06956_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/prot.340140302","volume":"14","author":"JN Varghese","year":"1992","unstructured":"Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A. & Colman, P. M. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327\u2013332 (1992)","journal-title":"Proteins"},{"key":"BFnature06956_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature05114","volume":"443","author":"RJ Russell","year":"2006","unstructured":"Russell, R. J. et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443, 45\u201349 (2006)","journal-title":"Nature"},{"key":"BFnature06956_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1086\/504723","volume":"193","author":"CL Cheung","year":"2006","unstructured":"Cheung, C. L. et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 193, 1626\u20131629 (2006)","journal-title":"J. Infect. Dis."},{"key":"BFnature06956_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM199709113371102","volume":"337","author":"RM Gulick","year":"1997","unstructured":"Gulick, R. M. et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734\u2013739 (1997)","journal-title":"N. Engl. J. Med."},{"key":"BFnature06956_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nrd2424","volume":"6","author":"E De Clercq","year":"2007","unstructured":"De Clercq, E. The design of drugs for HIV and HCV. Nature Rev. Drug Discov. 6, 1001\u20131018 (2007)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature06956_CR29","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1073\/pnas.201401198","volume":"98","author":"Y Ha","year":"2001","unstructured":"Ha, Y., Stevens, D. J., Skehel, J. J. & Wiley, D. C. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl Acad. Sci. USA 98, 11181\u201311186 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature06956_CR30","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1128\/AAC.42.12.3234","volume":"42","author":"CY Tai","year":"1998","unstructured":"Tai, C. Y. et al. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother. 42, 3234\u20133241 (1998)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature06956_CR31","first-page":"556","volume-title":"Data Collection and Processing","author":"Z Otwinowski","year":"1993","unstructured":"Otwinowski, Z. & Minor, W. in Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 556\u2013562 (SERC Daresbury Laboratory, Warrington, 1993)"},{"key":"BFnature06956_CR32","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760\u2013763 (1994)","DOI":"10.1107\/S0907444994003112"},{"key":"BFnature06956_CR33","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948\u20131954 (2002)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature06956_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1107\/S0108767390010224","volume":"47","author":"TA Jones","year":"1991","unstructured":"Jones, T. A., Zhou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110\u2013119 (1991)","journal-title":"Acta Crystallogr. A"},{"key":"BFnature06956_CR35","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004)","journal-title":"Acta Crystallogr. D"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature06956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature06956","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature06956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:08:29Z","timestamp":1744373309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature06956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,14]]},"references-count":35,"journal-issue":{"issue":"7199","published-print":{"date-parts":[[2008,6,26]]}},"alternative-id":["BFnature06956"],"URL":"https:\/\/doi.org\/10.1038\/nature06956","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,14]]},"assertion":[{"value":"14 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}